Indian healthtech in a soup as investors turn cautious on elusive profitability, lack of scale

Premium

The Indian healthtech sector may be facing a time of reckoning as investment dries up gradually.  As the $6.5 billion sector grapples with a plethora of issues ranging from delayed profitability, stagnant scale to offline competition, investors now seek businesses that are relatively closer or have already turned the corner and ......